APA (7th ed.) Citation

Raghavan, K., Dedeepiya, V. D., Srinivasan, S., Pushkala, S., Bharatidasan, S. S., Ikewaki, N., . . . Abraham, S. J. (2023). Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study. IBRO neuroscience reports, 15, 90-99. https://doi.org/10.1016/j.ibneur.2023.06.007

Chicago Style (17th ed.) Citation

Raghavan, Kadalraja, et al. "Beneficial Immune-modulatory Effects of the N-163 Strain of Aureobasidium Pullulans-produced 1,3-1,6 Beta Glucans in Duchenne Muscular Dystrophy: Results of an Open-label, Prospective, Exploratory Case-control Clinical Study." IBRO Neuroscience Reports 15 (2023): 90-99. https://doi.org/10.1016/j.ibneur.2023.06.007.

MLA (9th ed.) Citation

Raghavan, Kadalraja, et al. "Beneficial Immune-modulatory Effects of the N-163 Strain of Aureobasidium Pullulans-produced 1,3-1,6 Beta Glucans in Duchenne Muscular Dystrophy: Results of an Open-label, Prospective, Exploratory Case-control Clinical Study." IBRO Neuroscience Reports, vol. 15, 2023, pp. 90-99, https://doi.org/10.1016/j.ibneur.2023.06.007.